Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants

NCT03320707 ·Status: COMPLETED ·Phase: PHASE1

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids

NCT00489216 ·Status: TERMINATED ·Phase: NA

Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers

NCT05556863 ·Status: COMPLETED ·Phase: PHASE1

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

NCT07202598 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

NCT06450639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

NCT04551131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency

NCT02789397 ·Status: WITHDRAWN ·Phase: PHASE2

Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis

NCT01758588 ·Status: TERMINATED ·Phase: PHASE2

Glasdegib for Chronic Graft-Versus-Host Disease

NCT04111497 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency

NCT03733067 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization

NCT06435845 ·Status: TERMINATED ·Phase: PHASE2

A Study of LY3006072 in Healthy Participants

NCT01640249 ·Status: TERMINATED ·Phase: PHASE1

Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD

NCT02318082 ·Status: COMPLETED ·Phase: PHASE1

Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

NCT01084252 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

NCT03985423 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Zanubrutinib in Patients With IgG4-Related Disease

NCT04602598 ·Status: COMPLETED ·Phase: PHASE2

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

NCT03010436 ·Status: UNKNOWN ·Phase: PHASE2

Gastrointestinal STRING Test With Oral Immunotherapy

NCT04943744 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

NCT04322708 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

NCT01178216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

NCT07190261 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

NCT00105183 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)

NCT01066598 ·Status: TERMINATED ·Phase: PHASE2

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

NCT05416307 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

NCT02020889 ·Status: COMPLETED ·Phase: PHASE3